LRTI/pneumonia

LRTI/pneumonia in the News

Inhaled levofloxacin offers new option for treatment of infection in cystic fibrosis

Inhaled levofloxacin offers new option for treatment of infection in cystic fibrosis

Quinsair (levofloxacin) is licensed in the management...

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more